INDIGO
LIVE

Serial Number

79320764

Owner

Cube Biotech GmbH

Attorney

Raymond Wagenknecht

Filing Date

Apr 6, 2021

Add to watchlist:

No watchlists yet
View on USPTO

INDIGO Trademark

Serial Number: 79320764 • Registration: 6868385

INDIGO is a trademark filed by Cube Biotech GmbH on April 6, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Cube Biotech GmbH (10 trademarks)

Alfred-Nobel-Str. 10

Entity Type: 16

Trademark Details

Filing Date

April 6, 2021

Registration Date

October 11, 2022

Published for Opposition

July 26, 2022

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 20, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 31, 2023 FICS
FINAL DISPOSITION PROCESSED
Jan 31, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 11, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 11, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 11, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 26, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 26, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Jul 25, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 6, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 6, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 6, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 19, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2022 TROA
REFUSAL PROCESSED BY IB
Jan 10, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 22, 2021 RFCS
REFUSAL PROCESSED BY MPU
Dec 22, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 24, 2021 RFCR
NON-FINAL ACTION WRITTEN
Nov 23, 2021 CNRT
ASSIGNED TO EXAMINER
Nov 22, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 2, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 23, 2021 REPR